# Efficacy and Safety of Finerenone vs. Spironolactone in Patients With Primary Aldosteronism

> **NCT06164379** · PHASE4 · UNKNOWN · sponsor: **Shanghai Jiao Tong University School of Medicine** · enrollment: 150 (estimated)

## Conditions studied

- Primary Aldosteronism

## Interventions

- **DRUG:** Finerenone
- **DRUG:** Spironolactone

## Key facts

- **NCT ID:** NCT06164379
- **Lead sponsor:** Shanghai Jiao Tong University School of Medicine
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-12-16
- **Primary completion:** 2024-12-16
- **Final completion:** 2024-12-16
- **Target enrollment:** 150 (ESTIMATED)
- **Last updated:** 2023-12-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06164379

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06164379, "Efficacy and Safety of Finerenone vs. Spironolactone in Patients With Primary Aldosteronism". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06164379. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*